Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 5, 2018, after the close
10-Q filed Nov 5, 2018, 36 days after period end · 0001299130-18-000069
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $18.16M | $23.55M | $25.12M | $13.92M |
| Net Income | -$25.04M | -$22.02M | -$17.49M | $1.82M |
| EPS Diluted | -$0.19 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.19 |
| -$0.19 |
| $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
